Ganymede

Palo Alto, United States

Ganymede is a low-code PaaS for biotech software engineering that enables users to connect apps, ingest data, and construct pipelines.

$12.8M raised

Aug 2022

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Ganymede raised?

Ganymede has raised $12.8M in total funding. The most recent round was Series A. The last funding was announced in August 2022.

Who are Ganymede's investors?

Ganymede's investors include BoxGroup, Caffeinated Capital, SciFi VC.

Where is Ganymede headquartered?

Ganymede is headquartered in Palo Alto, United States.

What does Ganymede do?

Ganymede is a low-code PaaS for biotech software engineering that enables users to connect apps, ingest data, and construct pipelines.

What stage is Ganymede at?

Ganymede is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 9, 2022.

MLA

"Ganymede — Funding & Investors." VCBacked, August 9, 2022, https://www.vcbacked.co/company/ganymede. Accessed July 3, 2026.

APA

VCBacked. (2022). Ganymede — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/ganymede

Wikipedia (cite web)

{{cite web |title=Ganymede — Funding & Investors |url=https://www.vcbacked.co/company/ganymede |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 9, 2022.